Validity of Toluidine Blue test as a diagnostic tool for high risk oral potentially malignant disorders- a multicentre study in Sri Lanka
- PMID: 32923360
- PMCID: PMC7475265
- DOI: 10.1016/j.jobcr.2020.08.002
Validity of Toluidine Blue test as a diagnostic tool for high risk oral potentially malignant disorders- a multicentre study in Sri Lanka
Abstract
Introduction: - Early detection plays a major role to reduce the mortality of oral squamous cell carcinoma (OSCC). Many adjunctive techniques have emerged with claims of differentiating high risk oral potentially malignant disorders (OPMDs) from benign lesions. Toluidine blue (TB) test has been established as a diagnostic adjunct in detecting high risk OPMDs and early asymptomatic OSCCs. As majority of OSCC are preceded by OPMDs, recognition of them at an early stage is important in the management of this devastating disease.
Methods: -This study was conducted as a multi-center study prospectively for a period of 2 years. Sixty five patients presented with OPMDs were selected and TB test was performed followed by a biopsy for histopathological confirmation. Criterion validity was assessed with histological diagnosis of the incisional biopsy of the OPMD as a gold standard test verses TB test results.
Results: The sensitivity of the TB test was 68.3% and the specificity 63.1% with a false positive rate of 36.8% and false negative rate of 31.7%. However, the predictive value of the positive test was 80%.
Conclusion: - TB testing might be a potential adjunct diagnostic aid in identifying high risk OPMDs. Further studies with extensive sample size and different demographics are needed to validate our findings.
Keywords: Diagnostic aid; OPMD; OSCC; Prospective; Toluidine blue; Tool; Validation.
© 2020 Craniofacial Research Foundation. Published by Elsevier B.V. All rights reserved.
Figures
Similar articles
-
Evaluation of Noninvasive Adjuncts for Early Detection of Oral Cancer in Oral Potentially Malignant Disorders and Development of Risk-Based Management Strategies: Protocol for a Prospective Longitudinal Study.JMIR Res Protoc. 2025 May 28;14:e66285. doi: 10.2196/66285. JMIR Res Protoc. 2025. PMID: 40435493 Free PMC article.
-
Diagnostic Accuracy of Toluidine Blue Electrospun in Detecting Oral Potentially Malignant Disorders.Oral Dis. 2025 Feb;31(2):435-443. doi: 10.1111/odi.15161. Epub 2024 Oct 22. Oral Dis. 2025. PMID: 39435577
-
Evaluation of Mast Cells in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.Int J Dent. 2021 Aug 27;2021:5609563. doi: 10.1155/2021/5609563. eCollection 2021. Int J Dent. 2021. PMID: 34490052 Free PMC article.
-
Artificial intelligence and the diagnosis of oral cavity cancer and oral potentially malignant disorders from clinical photographs: a narrative review.Front Oral Health. 2025 Mar 10;6:1569567. doi: 10.3389/froh.2025.1569567. eCollection 2025. Front Oral Health. 2025. PMID: 40130020 Free PMC article. Review.
-
Accuracy of narrow band imaging for detecting the malignant transformation of oral potentially malignant disorders: A systematic review and meta-analysis.Front Surg. 2023 Jan 6;9:1068256. doi: 10.3389/fsurg.2022.1068256. eCollection 2022. Front Surg. 2023. PMID: 36684262 Free PMC article. Review.
Cited by
-
Salivary metabolomics in oral potentially malignant disorders and oral cancer patients-a systematic review with meta-analysis.Clin Oral Investig. 2024 Jan 16;28(1):98. doi: 10.1007/s00784-023-05481-6. Clin Oral Investig. 2024. PMID: 38225483
-
Accuracy of special histochemical staining methods in diagnosis of oral pathology: A systematic review and meta-analysis.Dent Res J (Isfahan). 2024 Jul 12;21:34. eCollection 2024. Dent Res J (Isfahan). 2024. PMID: 39188398 Free PMC article. Review.
-
Comparison of CEA and IgG serum levels in oral lichenoid lesions before and after treatment with topical corticosteroids.J Dent Res Dent Clin Dent Prospects. 2022 Spring;16(2):130-134. doi: 10.34172/joddd.2022.022. Epub 2022 Oct 15. J Dent Res Dent Clin Dent Prospects. 2022. PMID: 36561384 Free PMC article.
-
The Diagnostic Potential of Non-Invasive Tools for Oral Cancer and Precancer: A Systematic Review.Diagnostics (Basel). 2024 Sep 13;14(18):2033. doi: 10.3390/diagnostics14182033. Diagnostics (Basel). 2024. PMID: 39335712 Free PMC article. Review.
-
Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions.Cochrane Database Syst Rev. 2021 Jul 20;7(7):CD010276. doi: 10.1002/14651858.CD010276.pub3. Cochrane Database Syst Rev. 2021. PMID: 34282854 Free PMC article.
References
-
- Padmakumary G., Varghese C. 1997. Hospital cancer Registry. Thiruvananthapuram: Regional cancer centre; 2000; pp. 3–7. Annual Report.
-
- Rajendran R. sixth ed. Elsevier; Noida: 2009. Shafer's Textbook of Oral Pathology; pp. 80–218. Section 1 (Chapter 2) Benign and Malignant tumors of the Oral Cavity.
-
- Pignon J.P., le Maître A., Maillard E., Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomisedtrials and 17,346 patients. Radiother Oncol. 2009;92(1):4–14. - PubMed
-
- World Health Organization Global Health Observatory . World Health Organization; Geneva: 2018. https://gco.iarc.fr/today/data/factsheets/populations/144-sri-lanka-fact...
LinkOut - more resources
Full Text Sources
Research Materials